Cann logo

CAN - Cann Share Price

A$0.46 0.0  1.1%

Last Trade - 05/08/20

Sector
Healthcare
Size
Micro Cap
Market Cap £35.9m
Enterprise Value £32.3m
Revenue £1.60m
Position in Universe 823rd / 1835
Bullish
Bearish
Unlock CAN Revenue
Momentum
Relative Strength (%)
1m -50.9%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -77.8%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.006 0.000 0.000 0.56 2.35 1.00 16.0 +349.9%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 31 December 2019, Cann Group Ltd revenues increased from A$0K to A$569K. Net loss increased 71% to A$8.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Administration and corporate costs increase from A$3.5M to A$7M (expense), Interest decrease of 72% to A$249K (income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

CAN Revenue Unlock CAN Revenue

Net Income

CAN Net Income Unlock CAN Revenue

Normalised EPS

CAN Normalised EPS Unlock CAN Revenue

PE Ratio Range

CAN PE Ratio Range Unlock CAN Revenue

Dividend Yield Range

CAN Dividend Yield Range Unlock CAN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
CAN EPS Forecasts Unlock CAN Revenue
Profile Summary

Cann Group Limited is an Australia-based company, which is engaged in the cultivation of cannabis for human medicinal and research purposes. The Company has facilities to cultivate medicinal cannabis. It also focuses on manufacturing medicinal cannabis products. It focuses on developing and supplying cannabis, cannabis resin and medicinal cannabis products into the Australian market. It also focuses on supplying to overseas markets. The Company has a cannabis research license and cannabis cultivation license. The cannabis cultivation license allows the Company to produce Australian grown material that can be prescribed for patient use. It has research and development, and cultivation facilities in Australia. It focuses on plant genetics; breeding; cultivation; extraction; analysis and production techniques to facilitate the supply of medicinal cannabis for a range of diseases and medical conditions.

Directors
Last Annual June 30th, 2019
Last Interim December 31st, 2019
Incorporated January 30, 2015
Public Since May 4, 2017
No. of Shareholders: 14,128
No. of Employees: 40
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange Australian Stock Exchange - SEATS
Shares in Issue 142,422,063
Free Float (0.0%)
Eligible for
ISAs
SIPPs
CAN Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for CAN
Upcoming Events for CAN
Frequently Asked Questions for Cann
What is the Cann share price?

As of 05/08/20, shares in Cann are trading at A$0.46, giving the company a market capitalisation of £35.9m. This share price information is delayed by 15 minutes.

How has the Cann share price performed this year?

Shares in Cann are currently trading at A$0.46 and the price has moved by -76.29% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Cann price has moved by -74.7% over the past year.

What are the analyst and broker recommendations for Cann?

Of the analysts with advisory recommendations for Cann, there are there are currently 0 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Cann is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Cann next release its financial results?

Cann is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2020-12-31
What is the Cann dividend yield?

Cann does not currently pay a dividend.

Does Cann pay a dividend?

Cann does not currently pay a dividend.

When does Cann next pay dividends?

Cann does not currently pay a dividend.

How do I buy Cann shares?

To buy shares in Cann you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Cann?

Shares in Cann are currently trading at A$0.46, giving the company a market capitalisation of £35.9m.

Where are Cann shares listed? Where are Cann shares listed?

Here are the trading details for Cann:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: CAN
What kind of share is Cann?

Based on an overall assessment of its quality, value and momentum, Cann is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Cann share price forecast 2020?

Shares in Cann are currently priced at A$0.46. At that level they are trading at 0.305% discount to the analyst consensus target price of 0.00.

Analysts covering Cann currently have a consensus Earnings Per Share (EPS) forecast of -0.12 for the next financial year.

How can I tell whether the Cann share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cann. Over the past six months, the relative strength of its shares against the market has been -55.88%. At the current price of A$0.46, shares in Cann are trading at -47.82% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Cann PE Ratio?

We were not able to find PE ratio data for Cann.

Who are the key directors of Cann?

Cann's management team is headed by:

Allan McCallum - NEC
Philip Jacobsen - NVC
Douglas Rathbone - NID
Geoffrey Pearce - NID
Peter Crock - CEO
Richard Baker - CFO
Steven Notaro - OTH
Neil Belot - DRC
Geraldine Farrell - SEC
Reena Dahiya - CFO
Who are the major shareholders of Cann?

Here are the top five shareholders of Cann based on the size of their shareholding:

Aurora Cannabis Inc Corporation
Percentage owned: 16.55% (32.0m shares)
Tribeca Investment Partners Pty Ltd. Investment Advisor
Percentage owned: 4.95% (7.05m shares)
McCallum (Allan Donald) Individual Investor
Percentage owned: 2.89% (5.58m shares)
Jacobsen (Philip) Individual Investor
Percentage owned: 2.12% (4.09m shares)
Rohde (Allan Wayne) Individual Investor
Percentage owned: 1.37% (2.64m shares)
Similar to CAN
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.